Incidence of autism spectrum disorders: Changes over time and their meaning

Acta Paediatrica, International Journal of Paediatrics

Volumn 94, Issue 1, 2005, Pages 2-15

  Rutter, M ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Autism spectrum disorders; Diagnostic concept; Incidence; Measles mumps rubella vaccine; Thimerosal

Indexed keywords

MEASLES MUMPS RUBELLA VACCINE; THIOMERSAL;

AUTISM; ENTEROPATHY; ENVIRONMENTAL FACTOR; HUMAN; INCIDENCE; LITERATURE; PRIORITY JOURNAL; RELIABILITY; REVIEW; RISK FACTOR; SCREENING; SIDE EFFECT; VACCINATION;

AUTISTIC DISORDER; EMPIRICAL RESEARCH; ENVIRONMENT; HUMANS; INCIDENCE; MEASLES-MUMPS-RUBELLA VACCINE; PRESERVATIVES, PHARMACEUTICAL; THIMEROSAL;

EID: 12344320696     PISSN: 08035253     EISSN: None     Source Type: Journal    
DOI: 10.1080/08035250410023124     Document Type: Review

References (88)

1. Fombonne E. The epidemiology of autism: a review. Psychol Med 1998;29:769-86.
2. Fombonne E. Epidemiological surveys of autism and other pervasive developmental disorders: An update. J Autism Dev Disord 2003;33:365-82.
3. Medical Research Council. MRC review of autism research: epidemiology and causes. London: MRC; 2001.
4. Lotter V. Epidemiology of autistic conditions in young children: 1. Prevalence. Soc Psychiatry 1966;1:124-37.
5. Chakrabarti S, Fombonne E. Pervasive developmental disorders in preschool children. J Am Med Assoc 2001;285:3093-9.
6. Rutter M, Le Couteur A, Lord C. ADI-R autism diagnostic interview - revised. Manual. Los Angeles: Western Psychological Services; 2003.
7. Lord C, Rutter M, DiLavore PC, Le Couteur A. Autism diagnostic observation schedule - manual. Los Angeles CA: Western Psychological Services; 2001.
8. Baird G, Charman T, Baron-Cohen S, Cox A, Swettenham J, Wheelwright S, Drew A. A screening instrument for autism at 18 months of age: A 6-year follow-up study. J Am Acad Child Adolesc Psychiatry 2000;39:694-702.
9. Honda H, Shimizu Y, Misumi K, Niimi M, Ohashi Y. Cumulative incidence and prevalence of childhood autism in children in Japan. Br J Psychiatry 1996;169:228-35.
10. Kadesjö B, Gillberg C, Hagberg B. Autism and Asperger syndrome in seven-year-old children: A total population study. J Autism Dev Disord 1999;29:327-31.
11. Fombonne E, Simmons H, Ford T, Meltzer H, Goodman R. Prevalence of pervasive developmental disorders in the British nationwide survey of child mental health. J Am Acad Child Adolesc Psychiatry 2001;40:820-7.
12. Arvidsson T, Danielsson B, Forsberg P, Gillberg C, Johansson M, Kjellgren G. Autism in 3-6 year old children in a suburb of Goteborg, Sweden. Autism 1997;1:163-73.
13. Howlin P, Moore A. Diagnosis in autism: A survey of over 1200 parents. Autism 1997;1:135-62.
14. Heussler H, Polnay L, Marder E, Standen P, Lyn UC, Butler N. Prevalence of autism in early 1970s may have been underestimated [Letter]. Br Med J 2001;323:633.
15. Kanner L. Autistic disturbances of affective contact. Nervous Child 1943;2:217-50.
16. Wing L, Gould J. Severe impairments of social interaction and associated abnormalities in children: Epidemiology and classification. J Autism Dev Disord 1979;9:11-29.
17. Rutter M. Infantile autism. In: Shaffer D, Erhardt A, Greenhill L, editors. A clinician's guide to child psychiatry. New York: Free Press; 1985. p 41-68.
18. Starr EM, Kazak Berument S, Tomlins M, Papanikolaou K, Rutter M. Brief report: autism in individuals with Down syndrome. J Autism Dev Disord, in press.
19. Howlin P, Wing L, Gould J. The recognition of autism in children with Down syndrome. Implications for intervention and some speculations about pathology. Dev Med Child Neurol 1995;37:398-414.
20. Gillberg C, Coleman M. The biology of the autistic syndromes. London: MacKeith Press; 1992.
21. Rutter M, Bailey A, Bolton P, Le Couteur A. Autism and known medical conditions: myth and substance. J Child Psychol Psychiatry 1994;35:311-22.
22. Gillberg C, Coleman M. Autism and medical disorders: A review of the literature. Dev Med Child Neurol 1996;38:191-202.
23. Bailey A, Palferman S, Heavey L, Le Couteur A. Autism: The phenotype in relatives. J Autism Dev Disord 1998;28:381-404.
24. Le Couteur A, Bailey AJ, Goode S, Pickles A, Robertson S, Gottesman I, Rutter M. A broader phenotype of autism: The clinical spectrum in twins. J Child Psychol Psychiatry 1996;37:785-801.
25. Rutter M. Genetic influences and autism. In: Volkmar F, editor. Handbook of autism. 3rd ed. New York: John Wiley; in press.
26. Asperger H. Die 'Autistischen Psychopathen' im Kindesalter. Archiv für Psychiatrie und Nervkrankheiten 1944;117:76-136. Translated in: Frith U, editor. Autism and Asperger syndrome. Cambridge, UK: Cambridge University Press; 1991. p 37-92.
27. Asperger H. Die 'Autistischen Psychopathen' im Kindesalter. Archiv für Psychiatrie und Nervkrankheiten 1944;117:76-136. Translated in: Frith U, editor. Autism and Asperger syndrome. Cambridge, UK: Cambridge University Press; 1991. p 37-92.
28. Frith U. Autism and Asperger syndrome. Cambridge, UK: Cambridge University Press; 1991.
29. van Krevelen DA. Early infantile autism and autistic psychopathy. J Autism Child Schiz 1971;1:82-6.
30. Wing L. Asperger's syndrome: A clinical account. Psychol Med 1981;11:15-129.
31. Hippler K, Klicpera C. A retrospective analysis of the clinical case records of 'autistic psychopaths' diagnosed by Hans Asperger and his team at the University Children's Hospital, Vienna. Phil Trans R Soc Lond B 2003;358:291-301.
32. Gilchrist A, Green J, Cox A, Burton D, Rutter M, Le Couteur A. Development and current functioning in adolescents with Asperger syndrome: A comparative study. J Child Psychol Psychiatry 2001;42:227-40.
33. Rett A. Uber ein eigenartiges himatrophisches Syndrom bei Hyperammonie in Kindesalter. Wein Med Wochenschr 1966;116:723-6.
34. Hagberg B, Aicardi J, Dias K, Ramos O. A progressive syndrome of autism, dementia, ataxia and loss of purposeful hand use in girls: Rett syndrome; report of 35 cases. Ann Neurology 1983;14:471-9.
35. Witt-Engerström I, Gillberg C. Letter to the editor: Rett syndrome in Sweden. J Autism Dev Disord 1987;17:149-50.
36. Amir RE, van den Veyver IB, Wan M, Tran CQ, Francke U, Zoghbi HY. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet 1999;23:185-8.
37. Volkmar FR, Klin A, Marans W, Cohen DJ. Childhood disintegrative disorder. In: Cohen DJ, Volkmar FR, editors. Handbook of autism and pervasive developmental disorders. New York: John Wiley; 1997. p 47-59.
38. Volkmar FR, Klin A, Cohen DJ. Diagnosis and classification of autism and related conditions: Consensus and issues. In: Cohen DJ, Volkmar FR, editors. Handbook of autism and pervasive developmental disorders. 2nd ed. New York, Chichester: John Wiley; 1997. p 5-40.
39. Department of Developmental Services. Changes in population of persons with autism and pervasive developmental disorders in California's Developmental Services System: 1987 through 1998: a report to the Legislature March 1, 1999. Sacramento: California Health and Human Services Agency; 1999.
40. Department of Developmental Services. Autism spectrum disorders: changes in the California caseload an update: 1999 through 2002. Sacramento, CA: Department of Developmental Services, California Health and Human Services Agency; 2003.
41. Croen LA, Grether JK, Hoogstrate J, Selvin S. The changing prevalence of autism in California. J Autism Dev Disord 2002;32:207-15.
42. Blaxill MF, Baskin DS, Spitzer WO. Commentary on Croen et al. 2002. The changing prevalence of autism in California. J Autism Dev Disord 2003;33:223-6.
43. Croen LA, Grether JK. Response: A response to Blaxill, Baskin, and Spitzer on Croen et al. 2002. "The changing prevalence of autism in California". J Autism Dev Disord 2003;33:227-9.
44. MIND Institute. The epidemiology of autism in California: Report to the legislature on the principal findings from the epidemiology of autism in California: A Comprehensive Pilot Study. Davis: University of California; 2002.
45. Jick H, Kaye JA. Changes in risk of autism in the UK for birth cohorts 1990-1998 [Letter]. Epidemiology 2003;14: 630-1.
46. Jick H, Kaye JA. Epidemiology and possible causes of autism. Pharmacotherapy 2003;23:1524-30.
47. Gillberg C. Infantile autism and other childhood psychoses in a Swedish urban region: Epidemiological aspects. J Child Psychol Psychiatry 1984;25:35-43.
48. Steffenburg S, Gillberg C. Autism and autistic-like conditions in Swedish rural and urban areas: A population study. Br J Psychiatry 1986;149:81-7.
49. Gillberg C, Steffenburg S, Schaumann H. Is autism more common now than ten years ago. Br J Psychiatry 1991;158:403-9.
50. Bock G, Goode J, editors. Autism: Neural basis and treatment possibilities. Novartis Foundation Symposium 251. Chichester: John Wiley; 2003.
51. Webb EJV, Lobo S, Hervas A, Scourfield J, Fraser WI. The changing prevalence of autistic disorder in a Welsh health district. Dev Med Child Neurol 1997;39:150-2.
52. Magnusson P, Saemundsen E. Prevalence of autism in Iceland. J Autism Dev Disord 2001;31:153-63.
53. Powell J, Edwards A, Edwards M, Pandit BS, Sungum-Paliwal SR, Whitehouse W. Changes in the incidence of childhood autism and other autistic spectrum disorders in preschool children from two areas of the West Midlands, UK. Dev Med Child Neurol 2000;42:624-8.
54. Hillman RE, Kanafani N, Takahashi TN, Miles JH. Prevalence of autism in Missouri: changing trends and the effect of a comprehensive state autism project. Miss Med 2000;97:159-63.
55. Dales L, Hammer SJ, Smith NJ. Time trends in autism and in MMR immunization coverage in California. J Am Med Assoc 2001;285:1183-5.
56. Kaye JA, Melero-Montes M, Jick H. Mumps, measles, and rubella vaccine and the incidence of autism recorded by general practitioners: a time trend analysis. Br Med J 2001;322:460-3.
57. Honda H, Shimizu Y, Rutter M. No effect of MMR withdrawal on the incidence of autism: a total population study. Submitted 2004.
58. Lingam R, Simmons A, Andrews N, Miller E, Stowe J, Taylor B. Prevalence of autism and parentally reported triggers in a North East London population. Arch Dis Child 2003;88:666-70.
59. Gurney JG, Fritz MS, Ness KK, Sievers P, Newschaffer CJ, Shapiro EG. Analysis of prevalence trends of Autism Spectrum Disorder in Minnesota. Arch Pediatr Adolesc Med 2003;157:622-7.
60. Wakefield AJ, Murch SH, Anthony A, Linnell J, Casson DM, Berelowitz M, Dhillon AP, Thomson MA, Harvey P, Valentine A, Davies SE, Walker-Smith JA. Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet 1998;351:637-41.
61. Taylor B, Miller E, Farrington CP, Petropoulos M-C, Favot-Mayaud I, Li J, Waight PA. Autism and measles, mumps, and rubella vaccine: no epidemiological evidence for a causal association. Lancet 1999;353:2026-9.
62. Roger JH. The MMR question. Lancet 2000;356:160-1.
63. Wakefield AJ. Testimony before Congressional Oversight Committee on Autism and Immunization. 106th Congress of the United States of America, House of Representatives Committee on Government Reform, 6 April 2000.
64. Spitzer WO, Aitken KJ, Dell'Aniello S, Davis MWL. The natural history of autistic syndrome in British children exposed to MMR. Adverse Drug React Toxicol Rev 2001;20:160-3
65. Farrington CP, Miller E, Taylor B. MMR and autism: further evidence against a causal association. Vaccine 2001;19:3632-5.
66. Wakefield AJ. MMR vaccination and autism. Lancet 1999;354:949-50.
67. Thrower D. The MMR question. Lancet 2000;356:161.
68. Chen W, Landau S, Sham P, Fombonne E. No evidence for links between autism, MMR and measles virus. Psychol Med 2004;34:543-53.
69. Madsen KM, Hviid A, Vestergaard M, Schendel D, Wohlfahrt J, Thorsen P, Olsen J, Melbye M. A population-based study of measles, mumps, and rubella vaccination and autism. New Eng J Med 2002;347:1477-82.
70. Fombonne E, Chakrabarti S. No evidence for a new variant of measles-mumps-rubella-induced autism. Pediatrics 2001;108:e58.
71. Uchiyama T, Kurosawa M, Inaba Y. Does MMR vaccine cause so-called "regressive autism"? Submitted 2004.
72. Tuchman RF, Rapin I. Regression in pervasive developmental disorders: seizures and epileptiform electroencephalogram correlates. Pediatrics 1997;99:560-6.
73. Moffitt TE, Caspi A, Harkness AR, Silva PA. The natural history of change in intellectual performance: Who changes? How much? Is it meaningful? J Child Psychol Psychiatry 1993;34:455-506.
74. Fergusson D, Horwood LJ, Caspi A, Moffitt TE, Silva PA. The (artefactual) remission of reading disability: Psychometric lessons in the study of stability and change in behavioral development. Dev Psychol 1996;32:132-40.
75. Hill A, Rosenbloom L. Disintegrative psychosis of childhood: Teenage follow-up. Dev Med Child Neurol 1986;28:34-40.
76. Evan-Jones LG, Rosenbloom L. Disintegrative psychoses in childhood. Dev Med Child Neurol 1978;20:462-70.
77. Hendry CN. Childhood disintegrative disorder: Should it be considered a distinct diagnosis? Clin Psychol Rev 2000;20: 77-90.
78. Osterling JA, Dawson G, Munson JA. Early recognition of 1-year-old infants with autism spectrum disorder versus mental retardation. Dev Psychopathol 2002;14:239-51.
79. Bernard S, Enayati A, Redwood L, Roger H, Binstock T. Autism, a novel form of mercury poisoning. Med Hypotheses 2001;56:462-71.
80. Clarkson TW. The toxicology of mercury. Crit Rev Clin Lab Sci 1997;34:369-403.
81. Stratton K, Gable A, McCormick MC, editors. Immunization safety review: thimerosal-containing vaccines and neurodevelopmental disorders. Washington D.C.: National Academies Press; 2001.
82. Geier MR, Geier DA. Neurodevelopmental disorders after thimerosal-containing vaccines: A brief communication. Exp Biol Med 2003;228:660-4.
83. Geier MR, Geier DA. Response to comments by JR Mann. Exp Biol Med 2003;228:993-4.
84. Verstraeten T, Davis RL, DeStefano F, Lieu TA, Rhodes PH, Black SB, Shinefield H, Chen RT. Safety of thimerosal-containing vaccines: a two-phased study of computerized health maintenance organization databases. Pediatrics 2003;112:1039-48.
85. Hviid A, Stellfeld M, Wohlfahrt J, Melbye M. Association between thimerosal-containing vaccine and autism. J Am Med Assoc 2003;290:1763-6.
86. Madsen K, Lauritsen MB, Pedersen CB, Thorsen P, Plesner A-M, Andersen PH, Mortensen PB. Thimerosal and the occurrence of autism: negative ecological evidence from Danish population-based data. Pediatrics 2003;112:604-6.
87. Stehr-Green P, Tull P, Stellfeld M, Mortenson P-B, Simpson D. Autism and thimerosal-containing vaccines: Lack of consistent evidence for an association. Am J Prev Med 2003;25:101-6.
88. Institute of Medicine. Immunization safety review: vaccines and autism. Washington, D.C.: The National Academies Press; 2004.